M3, Inc. (MTHRY)

Revenue

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014
Medical Platform Segment Revenue	105.00B	91.57B	93.41B
Medical Platform Segment Revenue Growth	14.67%	-1.98%	0.34%
Evidence Solution Segment Revenue	24.61B	24.24B	26.70B
Evidence Solution Segment Revenue Growth	1.49%	-9.20%	-1.68%
Career Solution Segment Revenue	22.73B	20.91B	16.64B
Career Solution Segment Revenue Growth	8.67%	25.67%	14.47%
Site Solution Segment Revenue	52.65B	47.04B	33.03B
Site Solution Segment Revenue Growth	11.92%	42.45%	-6.43%
Patient Solution Segment Revenue	55.48B	21.92B	-
Patient Solution Segment Revenue Growth	153.10%	-	-
Overseas Segment Revenue	85.20B	80.57B	69.87B
Overseas Segment Revenue Growth	5.74%	15.32%	12.52%
Other Emerging Businesses Segment Revenue	2.31B	2.45B	2.63B
Other Emerging Businesses Segment Revenue Growth	-5.75%	-6.84%	-19.82%
Adjustments to Segment Revenue	-4.20B	-3.81B	-3.40B

EBIT

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014
Medical Platform Segment Profit	38.18B	34.11B	38.63B
Medical Platform Segment Profit Growth	11.93%	-11.71%	-6.13%
Evidence Solution Segment Profit	5.14B	4.35B	6.70B
Evidence Solution Segment Profit Growth	18.34%	-35.13%	-12.58%
Career Solution Segment Profit	5.73B	5.66B	4.78B
Career Solution Segment Profit Growth	1.27%	18.30%	2.95%
Site Solution Segment Profit	4.01B	5.42B	3.74B
Site Solution Segment Profit Growth	-26.02%	45.17%	-0.27%
Patient Solution Segment Profit	2.31B	824.00M	-
Patient Solution Segment Profit Growth	179.73%	-	-
Overseas Segment Profit	17.18B	14.75B	11.70B
Overseas Segment Profit Growth	16.51%	26.08%	-31.16%
Other Emerging Businesses Segment Profit	5.06B	1.00B	-290.00M
Other Emerging Businesses Segment Profit Growth	404.19%	-	-
Adjustments to Segment Profit	-2.38B	-3.13B	-863.00M

Key Performance Indicators

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014
Number of Medical Institutions Using M3 DigiKar	9.10K	7.70K	6.15K
Number of Medical Institutions Using M3 DigiKar Growth	18.18%	25.20%	29.47%

Updated Dec 31, 2025. Data Source: Fiscal.ai.